Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-01-23Clinical Trial Update: UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD Combination [Phase 2]
University of Arkansas announced the withdrawal of a Phase II trial evaluating a novel proteasome inhibitor and IMiD combination for multipl…
-
CLINICAL_TRIALS withdrawal · 2017-01-20Clinical Trial Update: Evaluation of Vertebral Compression Fracture Fixation With RF Kyphoplasty in Patients With Multiple Myeloma [Phase 4]
Phase 4 trial evaluating vertebral compression fracture fixation with RF kyphoplasty in patients with multiple myeloma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone [Phase 2]
This Phase 2 trial in patients aged 65 and older with newly diagnosed multiple myeloma compared two frontline regimens: sequential melphalan…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation. [NA]
A completed clinical trial assessing the impact of varying DMSO concentrations on hematopoietic recovery after autologous hematopoietic stem…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating pazopanib (GW786034) in subjects with relapsed or refractory multiple myeloma has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens [Phase 2]
Phase 2 study evaluating subcutaneous bortezomib regimens in relapsed/refractory multiple myeloma after prior IV bortezomib; the trial was t…
-
CLINICAL_TRIALS research · 2017-01-12Clinical Trial Update: Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)
An observational registry of Chinese patients with multiple myeloma treated with lenalidomide (Revlimid) has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies [Phase 1]
Phase 1 trial evaluating post-transplant autologous cytokine-induced killer (CIK) cells in high-risk hematologic malignancies has been compl…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma [EARLY_Phase 1]
A completed early-phase 1 safety study evaluating the combination of Velcade (bortezomib) and G-CSF in patients with multiple myeloma or mal…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients [Phase 2]
Phase 2 trial assessing safety of elotuzumab given over ~60 minutes with lenalidomide and dexamethasone in newly diagnosed or relapsed/refra…
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma [Phase 3]
Phase III trial of lenalidomide and dexamethasone with or without elotuzumab in relapsed or refractory multiple myeloma completed; results p…
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation [Phase 1]
Phase 1 trial evaluating MAGE-A3 protein plus AS15 as consolidation therapy after autologous stem cell transplantation in multiple myeloma p…
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies
A completed clinical trial assessing and comparing costs of two mobilization strategies for patients with multiple myeloma undergoing blood …
-
CLINICAL_TRIALS withdrawal · 2016-12-19Clinical Trial Update: Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant [Phase 2]
A Phase 2 study evaluating carfilzomib with dexamethasone in multiple myeloma patients who previously underwent a stem cell transplant was w…
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients [NA]
This clinical trial compares microtransplantation to autologous stem cell transplantation in patients with relapsed multiple myeloma; curren…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1, Phase 2]
This clinical trial update reports a completed Phase 1/2 study of arsenic trioxide plus vitamin C in patients with recurrent or refractory m…
-
CLINICAL_TRIALS withdrawal · 2016-12-15Clinical Trial Update: Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma [Phase 1]
Phase 1 trial evaluating a combination of bortezomib, arsenic trioxide, and melphalan in patients undergoing autologous stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma [NA]
Trial results for epoetin alfa in treating anemia in patients undergoing chemotherapy for multiple myeloma have been posted after completion…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder [Phase 3]
Phase 3 trial evaluating cyclosporine eye drops to prevent eye graft-versus-host disease in patients after donor stem cell transplant for he…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation. [Phase 2]
A Phase 2 trial completed evaluating an antiemetic therapy to prevent nausea and vomiting in multiple myeloma patients undergoing stem cell …
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma [Phase 1]
Phase 1 trial investigating expanded and activated autologous NK cells for treating multiple myeloma has completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
A completed clinical trial evaluating PET/MR and PET/CT imaging for detecting bone marrow lesions in conditions including multiple myeloma, …
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM) [Phase 1]
Phase 1 study evaluating Doxil, Vincristine and Dexamethasone with or without CC-5013 (lenalidomide) in relapsed or refractory multiple myel…
-
FDA approval · 2016-11-21FDA Approved: KYPROLIS — Supplemental Application (Onyx Pharmaceuticals, Inc.)
The FDA approved a supplemental application for KYPROLIS (carfilzomib) filed by Onyx Pharmaceuticals, Inc., marking an expanded or updated a…
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating eltrombopag for thrombocytopenia in patients with relapsed multiple myeloma was terminated; results were posted in …